Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bristol-Myers Squibb and MTT Multantiv Announce Non-Exclusive Licensing Agreement for Multivariate Calibration Methodology
Bristol Myers-Squibb Company, 01/06/09

Bristol-Myers Squibb Company and MTT Multantiv Oy announced that MTT Multantiv has granted Bristol-Myers Squibb non-exclusive licensing to its patent rights subject to U.S. Patent 6,629,041 for methods of multivariate calibration.

Today in Drug/Product Approvals...keeping you current

Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09

Safety concerns slow new drug review and approval processes
Formulary , 12/02/09

Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09

 See all of Drug/Product Approvals

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address